查询词典 chemotherapy

The patients achieved complete remission after induction course would enter the next grouping:the patients,aged 15-45 years, who had suitable donors and transplantation will were assigned to allogeneic stem-cell transplantation,and for the rest,they would be assigned to accept chemotherapy or autologous stem-cell transplantation randomly.CT and ASCT group both received early intensification and consolidation therapy orderly,which contained high-dose methotrexate,intermediate/high-dose cytarabine and high-dose or high-fraction cyclophosphamide,followed by ASCT or re-induction,later consolidation and maintenance chemotherapy for CT group.

符合入组条件的成人非Ph+ALL患者纳入研究，患者接受标准VDCP±L诱导治疗达到完全缓解(complete remission，CR)后进入下一阶段分组研究：年龄≤45岁，有合适供者及移植意愿者接受异基因造血干细胞移植allogeneic stem cell transplantation，Allo-SCT其余患者根据意愿分别接受自体造血干细胞移植(autologous stem cell transplantation，ASCT和化疗Chemotherapy。

RESULTS: Of the 44 patients, 25 received adjuvant chemotherapy after operation; 1 received operation alone; 18 received induction chemotherapy. Of the 18 patients, 7 received tumor resection after chemotherapy; 2 patients with primary mediastinal chorioepithelioma with multiple metastases received radiotherapy on residual disease after chemotherapy; 1 patient with postoperative abdominal metastasis and 1 with postoperative lung metastasis achieved complete remission after chemotherapy; 1 patient with mediastinal sinus tumor achieved partial remission after chemotherapy; 6 had poor response to chemotherapy and died of disease progression.

结果：44例患者中，25例行术后辅助化疗；1例单纯手术；18例行诱导化疗，其中7例患者化疗后肿瘤缩小行手术切除，2例原发纵隔绒癌伴多发转移患者化疗后行残留病灶放疗，1例术后腹腔转移和1例术后肺转移患者化疗后获得完全缓解，1例原发纵隔内胚窦瘤化疗后部分缓解，未做进一步治疗，6例患者化疗无效进展死亡。

Although Dr. Burstein agrees that metronomic chemotherapy alone "did not do all that much," he told Medscape that the combination with bevacizumab is encouraging and that a pilot study is being designed to look at the feasibility of combining bevacizumab with metronomic chemotherapy. The study will compare the combination treatment with bevacizumab alone, but it will not look at metronomic chemotherapy alone.28th Annual SABCS: Abstract 4. Presented Dec.

虽然Burstein医师同意仅接受节律性化学疗法几乎是没有帮助，但他向Medscape表示，结合bevacizumab的合并疗法是有潜力的，而且已经有初期试验检验结合bevacizumab与节律性化学疗法的可行性；这项试验将会比较合并试验与仅接受bevacizumab治疗的反应，但并不会检验仅接受节律性化学疗法的效果。

Objective To detect the effect of cyclophosphamide administered by means of metronomic chemotherapy combined maximum tolerated dose chemotherapy on the angiogenesis, carcinogenesis and metastasis of Lewis lung cancer on C57BL/6 mouse model. Method The mice were randomly divided into four groups:（1）metronomic chemotherapy group,（2）MTD group,（3）combination group（metronomic chemotherapy combined MTD group）,（4）control group.

目的 探讨环磷酰胺节律化疗联合最耐受量化疗对小鼠Lewis 肺癌肿瘤生长、血管生成和远处转移的影响方法荷瘤小鼠随机分4组：分别（1）CTX节律化疗组；（2）MTD组；（3）联合组（CTX节律化疗联合MTD化疗）；（4）对照组。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什么选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

Despite the poor response rates in the chemotherapy-alone group, Dr. Burstein believes that metronomic chemotherapy combined with bevacizumab should be investigated further, given the tolerability of the agents and the preclinical rationale for efficacy. When asked why cyclophosphamide and methotrexate were selected for metronomic chemotherapy, he observed that many patients in this setting are already somewhat chemotherapy-resistant.

尽管只接受化学疗法的病患反应率很低，Burstein医师相信节律性化学疗法加上bevacizumab应该进一步研究，因为该药物的耐受性良好，而且临床前实验认为是有效的；当被问到为什麼选择cyclophosphamide与methotrexate作为节律性化学疗法的药物，他观察发现，许多病患在这个时候已经对许多化学疗法产生抗药性。

The methods were: First, use of conventional chemotherapy and acquired lesions were reduced, the mobilization of peripheral blood stem cells in blood cell sorter to take peripheral blood stem cells, and then high-dose chemotherapy CVpP program, 24-48 hours after chemotherapy, stem-cell reinfusion.

其方法是：首先采用常规化疗后取得病灶缩小者，动员外周血干细胞后用血细胞分离仪采取外周血干细胞后，再用高剂量化疗CVpP方案，化疗后24-48小时干细胞回输。

Resultantly, the scores of the syndromes as indicated in the cancer group were higher (Qi deficiency syndrome:37.62±16.69 vs 19.92±13.36; blood stasis syndrome:28.14±9.34 vs 12.60±8.80) than those in the non-cancer group. The incidence of the syndromes in the latter group was lower (Qi deficiency syndrome :25.7% vs 67.0%; blood stasis syndrome :21.1% vs 87.0%) than the former group.The scores of the syndromes in the late cancer stage were higher than those in the early stage, but the incidences of the diagnostic patterns for the syndromes were similar. The scores of qi deficiency were higher during chemotherapy than after or without chemotherapy, those of blood stasis were similar during, after or without chemotherapy, those of the syndromes were not different with or without radiation therapy, and those of the syndromes were reduced by the two-week Traditional Chinese medicine therapy.

结果显示癌症组的气虚分数37.62±16.69比非癌症组的19.92±13.36高；癌症组的血瘀分数28.14±9.34也比非癌症组的12.60±8.80高；非癌症组气虚证的发生率25.7%比癌症组的67.0%低；非癌症组血瘀证的发生率21.1%也比癌症组的87.0%低；癌症晚期比早期有较高的气虚和血瘀分数，但证型发生率两者相似；正在化疗中的气虚分数比曾经化疗或无化疗者高，但血瘀分数则三者相似；放疗有或无不会影响癌症患者的气虚或血瘀分数；中医治疗介入两周能减少癌症患者的气虚和血瘀分数。

objective to evaluate the effect of endoscopic splender dilation combined with photodynamic therapy and local chemotherapy in treatment of esophagocadial cancer stenosis.methods 91 patients with advanced esophagocadial cancer were divided into two groups: the control group (to receive pdt and local chemotherapy) and the test group (to receive endoscopic splender dilation plus pdt and local chemotherapy).

目的 评价经内镜探条扩张术联合光动力疗法及局部化疗治疗食管贲门癌性狭窄的临床疗效。方法食管贲门癌患者91例，按治疗方法分为对照组和联合扩张治疗组（经内镜探条扩张联合pdt及局部化疗）。

All the patients had accepted TP chemotherapy and preponderated over 2 cycles,taxol 135 mg/m2,d1,cisplatin 20 mg/m2,d1-4.The chemotherapy was repeated every 21 days on two cycles.Results Among these 34 patients the complete responsewas 0,partial responsewas 3(8.82%),stable diseasewas 6(17.65%),progressive diseasewas 25(73.53%).The main toxicity,reactions were nausea,vomiting and hematologic toxicity.Conclusions TP regimen on advanced NSCLC after failure of NP show slow effectiveness. non-small cell lung cancer ; chemotherapy ; NP regimen ; TP regimen

本文回顾性分析我科自2002年6月—2004年12月间将应用NP方案进展的晚期NSCLC患者改用TP方案治疗的34例临床资料，观察并比较该方案的疗效、毒副反应。1资料与方法1.1临床资料34例经病理组织学及细胞学证实为NSCLC，男性21例，女性13例，年龄35~78岁，平均年龄54岁；鳞癌20例，腺癌12例，腺鳞癌2例，Ⅲb期24例，Ⅳ期10

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。